![Young-Seok Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Young-Seok Lee
Directeur Général chez
ICURE PHARMACEUTICAL INCORPORATION
Fortune : 36 949 $ au 31/08/2025
Profil
Young-Seok Lee held the position of Chief Executive Officer & Director at Icure Pharmaceutical Inc. starting in 2022.
Additionally, Mr. Lee is the Head of Equities at Korea Investment Management Co., Ltd.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2025 | 23 637 ( 0,06% ) | 36 949 $ | 31/08/2025 |
Postes actifs de Young-Seok Lee
| Sociétés | Poste | Début |
|---|---|---|
| ICURE PHARMACEUTICAL INCORPORATION | Directeur Général | 31/03/2022 |
Korea Investment Management Co., Ltd.
 Korea Investment Management Co., Ltd. Investment ManagersFinance KIM offers a broad array of asset management capabilities that span all segments of active and passive investments from traditional to alternative assets. The firm is a socially responsible investor which aims to enhance the quality of engagement between investors and companies on important governance and sustainability issues and to create long-term value for shareholders. They place an emphasis on fundamentals rather than short-term momentum, while monitoring market risks at all times. | Head-Equity Investments | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
30
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Korea Investment Management Co., Ltd.
Korea Investment Management Co., Ltd. Investment ManagersFinance KIM offers a broad array of asset management capabilities that span all segments of active and passive investments from traditional to alternative assets. The firm is a socially responsible investor which aims to enhance the quality of engagement between investors and companies on important governance and sustainability issues and to create long-term value for shareholders. They place an emphasis on fundamentals rather than short-term momentum, while monitoring market risks at all times. | Finance |
Icure Pharmaceutical Inc.
 Icure Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures transdermal drug delivery products | Health Technology |
